BEGIN:VCALENDAR
PRODID:-//Flo Inc.//FloSoft//EN
BEGIN:VEVENT
DTSTART:20210324T120000Z
DTEND:20210324T130000Z
LOCATION:<p>Zoom Meeting -&nbsp;Meeting invitations will be sent prior to the Grand Rounds event</p>
<h2>Speaker</h2>
<p align="center" style="text-align: left;"><b>Brigitte Widemann, MD<br /></b>Head, Pharmacology &amp; Experimental Therapeutics Section<br />Chief, Pediatric Oncology Branch<br />Deputy Director, Center for Cancer Research<br />National Cancer Institute<br />Bethesda, MD</p>
DESCRIPTION;ENCODING=QUOTED-PRINTABLE:
SUMMARY:Progress in the Development of Effective Therapies for NF1 Related Tumors
PRIORITY:3
END:VEVENT
END:VCALENDAR
